Triple vessel disease, stent implantation, hypertension, eGFR, and uric acid are independent predictors of MACE in CAD patients that should be monitored early.
Having triple vessel disease, stent implantation, hypertension, and eGFR or uric acid independently predicted MACE in patients with CAD after long-term follow-up. Fortunately, these factors are modifiable and should be identified and monitored early.
Tsai et al. (Wed,) studied this question.